Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BMRN
Recent news which mentions BMRN
< Previous
1
2
3
4
5
6
7
8
Next >
BioMarin Sells Priority Review Voucher For $110M
February 09, 2022
Tickers
BMRN
Tags
BMRN
Market News
Health Care
From
Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
Tickers
ADGI
ALLK
ALNY
ARGX
Tags
ADGI
JSPR
NKTR
From
MarketWatch
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
News
Health Care
Market News
From
Benzinga
2 Under-the-Radar Biotech Picks to Buy For The Long Haul
December 24, 2021
Tickers
BMRN
CORT
CPRX
Tags
CPRX
Recent Press Releases
CORT
From
Motley Fool
This Favorable Sign Appears On Biomarin Pharmaceutical's Chart
November 25, 2021
Tickers
BMRN
Tags
Trading Ideas
BMRN
Market News
From
Benzinga
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
November 24, 2021
Tickers
BMRN
Tags
Trading Ideas
BMRN
Market News
From
Benzinga
Where Biomarin Pharmaceutical Stands With Analysts
November 22, 2021
Tickers
BMRN
Tags
BZI/AAR
Benzinga
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
Tickers
ADBE
AIP
ALNY
ASPU
Tags
FMX
DTC
GFS
From
Benzinga
10 Biggest Price Target Changes For Monday
November 22, 2021
Tickers
ALNY
AMGN
ATVI
BMRN
Tags
ETSY
ATVI
CMPS
From
Benzinga
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
November 20, 2021
Tickers
BMRN
Tags
Recent Press Releases
BMRN
Market News
From
Motley Fool
FDA Conditionally Approves Biomarin's Dwarfism Drug
November 19, 2021
Tickers
BMRN
Tags
Health Care
News
Long Ideas
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
NVS
RHHBF
Market News
From
Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Tickers
ACRX
AMRN
ATHX
AYTU
Tags
MDWD
Earnings
URGN
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
Tickers
AADI
AMYT
BMRN
BYSI
Tags
Penny Stocks
LQDA
GILD
From
Benzinga
BioMarin's Q3 Net Income Hit By Lower Product Sales
October 28, 2021
Tickers
BMRN
Tags
General
Benzinga
Briefs
From
Benzinga
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
BMRN
Tags
BMRN
Market News
From
Motley Fool
Biomarin Pharmaceutical: Q3 Earnings Insights
October 27, 2021
Tickers
BMRN
Tags
Market News
BMRN
Earnings
From
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Tickers
ABBV
ADAP
ALIM
ALKS
Tags
RGEN
TARO
CNTX
From
Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
Tickers
BLUE
BMRN
BMY
JNJ
Tags
LEGN
JNJ
BMY
From
Motley Fool
The Smartest Stocks to Buy With $250 Right Now
October 22, 2021
Tickers
BMRN
FRPT
GRWG
Tags
BMRN
Market News
GRWG
From
Motley Fool
Barron's Latest Picks And Pans: Amazon, Apple, Chevron, Citigroup, Dell And More
October 16, 2021
Tickers
AAPL
AMZN
BMRN
C
Tags
DELL
LLY
Benzinga
From
Benzinga
Stifel Upgrades This Pharma Stock On Prospective FDA Approval For Dwarfism Drug
September 09, 2021
Tickers
BMRN
Tags
Analyst Ratings
BMRN
dwarfism
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
Tickers
ALGS
AMRN
APEN
APP
Tags
UPWK
LBRT
BZI/Ratings
From
Benzinga
Price To Earnings Ratio Insights For Biomarin Pharmaceutical
September 07, 2021
Tickers
BMRN
Tags
News
Market News
BZI/PE
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 07, 2021
Tickers
ADAP
APOP
BMRN
FWP
Tags
Benzinga
Markets
NRXP
From
Benzinga
FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
September 07, 2021
Tickers
BMRN
Tags
BMRN
Biotech
FDA
From
Benzinga
Drug For Short-Limbed Dwarfism From Biomarin Wins European Approval
August 27, 2021
Tickers
BMRN
Tags
achondroplasia
General
European Commission
From
Benzinga
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
August 20, 2021
Tickers
ASND
BMRN
Tags
ASND
BMRN
Market News
From
Motley Fool
BioMarin Bounces Back With Solid Q2 Earnings, Nudges Up 2021 Guidance
July 29, 2021
Tickers
BMRN
Tags
General
Benzinga
Biotech
From
Benzinga
BioMarin Pharmaceutical inc (BMRN) Q2 2021 Earnings Call Transcript
July 29, 2021
Tickers
BMRN
Tags
Market News
BMRN
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today